1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validations
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market
Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers,
Challenges, Trends
4.
Voice of Customer
5. Global Peanut Allergy Treatment Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others)
5.2.2. By Route of Administration (Oral, Intravenous, Others)
5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online
Pharmacies)
5.2.4. By Region
5.2.5. By Company (2022)
5.3.
Product Map
5.3.1. By Drug Class
5.3.2. By Route of
Administration
5.3.3. By Distribution
Channel
5.3.4. By Region
6. North America Peanut
Allergy Treatment Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Drug Class
6.2.2. By Route of Administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3.
North America: Country Analysis
6.3.1. United States Peanut
Allergy Treatment Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Class
6.3.1.2.2.
By Route of Administration
6.3.1.2.3.
By Distribution Channel
6.3.2. Canada Peanut
Allergy Treatment Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Class
6.3.2.2.2.
By Route of Administration
6.3.2.2.3.
By Distribution Channel
6.3.3. Mexico Peanut
Allergy Treatment Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Class
6.3.3.2.2.
By Route of Administration
6.3.3.2.3.
By Distribution Channel
7. Europe Peanut
Allergy Treatment Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Route of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3.
Europe: Country Analysis
7.3.1. France Peanut
Allergy Treatment Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Route of Administration
7.3.1.2.3.
By Distribution Channel
7.3.2. Germany Peanut
Allergy Treatment Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Route of Administration
7.3.2.2.3.
By Distribution Channel
7.3.3. United Kingdom
Peanut Allergy Treatment Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Route of Administration
7.3.3.2.3.
By Distribution Channel
7.3.4. Italy Peanut Allergy
Treatment Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Class
7.3.4.2.2.
By Route of Administration
7.3.4.2.3.
By Distribution Channel
7.3.5. Spain Peanut Allergy
Treatment Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Class
7.3.5.2.2.
By Route of Administration
7.3.5.2.3.
By Distribution Channel
8. Asia-Pacific Peanut
Allergy Treatment Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Route of Administration
8.2.3. By Distribution Channel
8.2.4.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. China Peanut Allergy
Treatment Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Route of Administration
8.3.1.2.3.
By Distribution Channel
8.3.2. India Peanut Allergy
Treatment Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Route of Administration
8.3.2.2.3.
By Distribution Channel
8.3.3. Japan Peanut Allergy
Treatment Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Route of Administration
8.3.3.2.3.
By Distribution Channel
8.3.4. South Korea Peanut
Allergy Treatment Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Route of Administration
8.3.4.2.3.
By Distribution Channel
8.3.5. Australia Peanut
Allergy Treatment Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Route of Administration
8.3.5.2.3.
By Distribution Channel
9. South America Peanut
Allergy Treatment Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Route of Administration
9.2.3. By Distribution Channel
9.2.4.
By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Peanut
Allergy Treatment Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Route of Administration
9.3.1.2.3.
By Distribution Channel
9.3.2. Argentina Peanut
Allergy Treatment Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Route of Administration
9.3.2.2.3.
By Distribution Channel
9.3.3. Colombia Peanut
Allergy Treatment Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Route of Administration
9.3.3.2.3.
By Distribution Channel
10. Middle East and
Africa Peanut Allergy Treatment Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Route of Administration
10.2.3. By Distribution Channel
10.2.4.
By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Peanut
Allergy Treatment Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Drug Class
10.3.1.2.2.
By Route of Administration
10.3.1.2.3.
By Distribution Channel
10.3.2. Saudi Arabia Peanut
Allergy Treatment Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Drug Class
10.3.2.2.2.
By Route of Administration
10.3.2.2.3.
By Distribution Channel
10.3.3. UAE Peanut Allergy
Treatment Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Drug Class
10.3.3.2.2.
By Route of Administration
10.3.3.2.3.
By Distribution Channel
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers & Acquisitions
12.3.
Product Launches
13. Global Peanut Allergy Treatment Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Products
15.
Competitive Landscape
15.1.
Business Overview
15.2.
Product Offerings
15.3.
Recent Developments
15.4.
Key Personnel
15.5.
SWOT Analysis
15.5.1. Vedanta Biosciences,
Inc.
15.5.2. Alladapt
Immunotherapeutics, Inc.
15.5.3. Regeneron
Pharmaceuticals Inc.
15.5.4. Aravax Pty Ltd
15.5.5. Teva Pharmaceutical
Industries Limited
15.5.6. Prota Therapeutics
Pty Ltd.
15.5.7. Aimmune
Therapeutics, Inc. (Nestle)
15.5.8. DBV Technologies SA
15.5.9. Sanofi SA
16. Strategic Recommendations